ArticleThe journal of allergy and clinical immunology. Global2026
Hereditary alpha-tryptasemia demonstrates relative basophil enrichment without signs of cellular hyperreactivity.
Article in The journal of allergy and clinical immunology. Global, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hereditary alpha-tryptasemia (HαT) is an autosomal dominant trait caused by increased tryptase alpha/beta 1 ( Objective: Our aim was to compare basophil proportions, MRGPRX2 expression, and responsiveness to IgE-dependent and IgE-independent activation in individuals with HαT, individuals with indolent systemic mastocytosis (ISM), and healthy controls (HCs). Methods: Peripheral blood was obtained from individuals with HαT (n = 20), individuals with ISM (n = 31), and HCs (n = 8). Basophils were identified by flow cytometry; relative basophil frequencies and surface expression of FcεRI and MRGPRX2 were assessed. Basophil activation was evaluated by CD63 upregulation following stimulation with Results: Relative basophil proportions were higher in subjects with HαT than in subjects with ISM. FcεRI surface expression was preserved in those with HαT but reduced in those with ISM, whereas MRGPRX2 expression was not detected at functionally relevant levels. Basophils from individuals with HαT displayed nonresponsiveness to anti-FcεRI more frequently. In contrast, response to formylmethionyl-leucyl-phenylalanine was higher in subjects with ISM than in subjects with HαT and showed a trend of being higher than in HCs. Mastoparan- and compound 48/80-induced activation was undetectable across groups. Conclusion: HαT features enriched basophil frequency but lacks functional hyperreactivity. An increased rate of nonresponse to FcεRI cross-linking distinguishes HαT from ISM, indicating condition-specific FcεRI signaling dysregulation rather than uniform basophil dysfunction in mast cell-associated disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.